-+ 0.00%
-+ 0.00%
-+ 0.00%

On March 4, 2026, Tyra Biosciences Agreed To Issue And Sell 4,000,000 Shares Of Common Stock To A Large Investment Management Firm At A Purchase Price Of $31.50 Per Share; Co. Expects To Receive $126.0M In Gross Proceeds Upon Settlement, Before Deducting Fees And Other Expenses Payable By It

Benzinga·03/04/2026 22:23:54
Listen to the news